Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.04
+0.04 (0.57%)
At close: Sep 16, 2025, 4:00 PM EDT
7.04
0.00 (0.00%)
After-hours: Sep 16, 2025, 4:10 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $161.37 million as of September 16, 2025. Its market cap has increased by 5.81% in one year.
Market Cap
161.37M
Enterprise Value
154.88M
1-Year Change
5.81%
Ranking
Category
Stock Price
7.04
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $161.37M, an increase of 6.08%. That is a compound annual growth rate of 5.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 160.45M | 3.20% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |